IMMUNIC, INC., 2026-03-04
An SEC Form D private-offering notice from New York, a $200,000,000 filer-stated offering target in Biotech. Filed 2026-03-04. The source filing is one click away. For companies that filed this week, open the live feed.
What this filing says
Clinical-stage biotechnology company developing oral, small-molecule therapies for chronic inflammatory, autoimmune, and neurologic diseases, including relapsing multiple sclerosis.
This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.
Other Form D filings from the same week
each with its own page and its own EDGAR source- Persevere Therapeutics Inc., 2026-03-04, $5M, Chesterbrook, PA
- Parcel Biosciences, Inc., 2026-03-04, $13.2M, San Francisco, CA
- GenoPalate, Inc., 2026-03-04, $3M, Milwaukee, WI
- GUARDIAN BIOMEDICAL CORP., 2026-03-03, $250K, Tampa, FL
- Tidal Diagnostic Solutions Inc., 2026-03-03, $500K, Scarborough, ME
- Allyx Therapeutics, Inc., 2026-03-03, $4M, New Haven, CT
The Monday digest, free
A summary of who raised money last week: the ones worth a call first, then every company that filed, by state and sector. One email, Monday mornings. No spam, unsubscribe anytime.
By subscribing you agree to our Terms and Privacy Policy.